Engineering Genes, Vectors, Constructs and Clones

Protein expression is never a simple task and the demand for high-quality biotherapeutic proteins continues to grow. Bottlenecks arise frequently because functional recombinant proteins are difficult to produce, thus protein expression engineers are often forced to return to the drawing board. This usually requires designing new cloning schemes, including lengthy verification and sequence analysis of the gene or protein of interest, moving a gene from one vector to another, transfecting the vector in an alternative host, re-characterizing the expressed protein or any of the above—an inefficient, time-consuming and expensive process.

Cambridge Healthtech Institute’s Seventh Annual Engineering Genes, Vectors, Constructs and Clones conference continues the tradition of applying effective engineering strategies for protein expression and production research leading to functional biotherapeutic products. Learn from seasoned, savvy researchers as they share their real-world experiences, applications and results.